Rural Health Information Hub Latest News

Rural Health Value

The Rural Health Value team has released a revised Value-Based Care Strategic Planning Tool (VBC Tool).  The web-based tool is designed for rural health care leaders to assess organizational capacities or capabilities (e.g., resources, processes, infrastructure) to deliver value-based care as part of their strategic planning process. Upon completion of the on-line tool, a report is provided that can be used to support strategic planning and prioritize action plans that are responsive to a changing health care payment and delivery environment.  Supplemental resources, including an action planning tool and a brief guide to assist leaders in preparing their organization for value-based care are also available.

Value-Based Care Assessment Tool (updated December 2021)
This online tool helps the organization assess readiness for the shift of healthcare payments from volume to value. The resulting report may be used to guide the development of action plans. Supplemental resources, including an action planning tool and a brief guide to assist leaders in preparing their organization for value-based care are also available.

Link:   Value-Based Care Assessment Tool | RuralHealthValue.org (uiowa.edu)

Dental Assistant Workforce Needs Assessment

The National Network for Oral Health Access (NNOHA) is conducting a needs assessment to better understand the current state and needs of community health centers’ dental assistant workforce. The results of this needs assessment will inform the development of national resources to assist with the recruitment, retention and training of dental assistants. The needs assessment will take five minutes to complete and is intended for dental leadership and dental assistants working in community health centers. By completing the needs assessment, you will be eligible to enter a drawing for a $50 Amazon gift card. The needs assessment will close on January 31, 2022. Click here to complete.

Study Finds Lack of High School Education Predicts Hesitancy

A lack of a high school education was the most important predictor of COVID-19 vaccine hesitancy in 3,142 U.S. counties, finds a study yesterday in the American Journal of Infection Control. Of all reasons cited for COVID-19 vaccine hesitancy, a lack of trust in the vaccines (55%) was the most common, followed by worries about side effects (48%) and low trust in the government (46%). Five of the 10 most common reasons given for vaccine hesitancy were related to a lack of knowledge about potential side effects, benefits, effectiveness and risks of being unvaccinated.

COVID-19 Claims Reimbursement for Uninsured Patients

Health Resources and Services Administration is accepting requests for claims reimbursement to healthcare providers, generally at Medicare rates, for testing uninsured individuals for COVID-19, for treating uninsured individuals with a COVID-19 primary diagnosis and for COVID-19 vaccine administration to the uninsured. Applications are accepted on an ongoing basis. A separate program, the HRSA COVID-19 Coverage Assistance Fund, is available to reimburse providers for COVID-19 vaccine administration to underinsured individuals whose health plan either does not include COVID-19 vaccination as a covered benefit or covers COVID-19 vaccine administration but with cost-sharing.

COVID-19: New HCPCS Code for Remdesivir Antiviral Medication

Following the recent statement from the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel regarding therapies for the COVID-19 Omicron variant, CMS created HCPCS code J0248 for VEKLURY™ (remdesivir) antiviral medication when administered in an outpatient setting. This code is available for use by all payers and is effective for dates of service on or after December 23, 2021:

  • Long descriptor: Injection, remdesivir, 1 mg
  • Short descriptor: Inj, remdesivir, 1 mg

Medicare Administrative Contractors (MACs) determine Medicare coverage when there is no national coverage determination, including in cases when providers use FDA-approved drugs for indications other than what is on the approved label. The MACs consider the major drug compendia, authoritative medical literature and accepted standards of medical practice to determine medical necessity when considering coverage. Therefore, the MACs will determine Medicare coverage for HCPCS code J0248 for VEKLURY™ (remdesivir) administered in an outpatient setting.

Your MAC will share coverage and claims processing information for J0248. Contact your MAC if you have questions about coverage.

CDC Releases “Rural Considerations for Vaccine Confidence and Uptake Strategies”

The Centers for Disease Control and Prevention (CDC) has released another COVID-related rural resource that may be of interest.  A “Rural Considerations” addendum was recently added to its field guide for conducting a Rapid Community Assessment (RCA).

An RCA is a process for quickly collecting community insights about a public health issue in order to inform program design. The assessment involves reviewing existing data and conducting community-based interviews, listening sessions, observations, social listening, and surveys.  In addition to the rural considerations addendum, the CDC RCA webpage provides an assessment guide and tools for those who wish to better understand their community’s needs regarding COVID-19 vaccine acceptance and uptake among adults, adolescents, and children.  Addendums for conducting RCAs in tribal communities and among adolescent populations were also recently posted to the webpage.

The original COVID-19 Vaccination Field Guide: 12 Strategies for Your Community presents evidence-based strategies being applied in communities across the country to increase COVID-19 vaccine confidence and uptake. To help rural communities apply these strategies, the addendum includes rural considerations and examples for the 12 strategies based on successes in the field and input from health departments and rural health organizations.

State and local health departments, community- and faith-based organizations, and local nonprofits are encouraged to try a combination of these strategies to increase vaccination rates.  Please share widely!  Questions may be directed to ruralhealth@cdc.gov.

CMS Takes Action to Lower Out of Pocket Medicare Part D Prescription Drug Costs

Today, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would make updates to the Medicare Advantage (MA) and Medicare Part D programs that would lower out-of-pocket prescription drug costs for beneficiaries with Medicare Part D and improve price transparency and market competition. The proposed rule would improve beneficiaries’ experiences with MA and Part D, with a strong emphasis on individuals who are dually eligible for Medicare and Medicaid. Ultimately, CMS is taking action to hold MA and Part D plans to a higher standard in offering benefits and improve health equity in the programs.

“We are dedicated to ensuring older Americans and those with disabilities who are served by the Medicare program have access to quality, affordable health care, including prescription drugs and therapies,” said CMS Administrator Chiquita Brooks-LaSure. “Today’s proposed actions follow our guiding principles by improving health equity and enhancing access to prescription medications.”

In recent years, more Part D plans and pharmacies have entered into arrangements—called price concessions—where plans pay less money to pharmacies for dispensed drugs if the pharmacies do not meet certain metrics. However, there is no public visibility on these pharmacy price concessions, and these lower prices are not passed along to the beneficiary at the point of sale. In late 2018, CMS sought comment on a policy that would require Part D plans to apply all price concessions they receive from network pharmacies at the point of sale, which would reduce beneficiary cost-sharing. Having considered the comments, CMS is now proposing this policy, which would take effect January 1, 2023, to reduce beneficiaries’ Medicare Part D out-of-pocket costs and improve price transparency and market competition in the Part D program.

The proposed rule also takes steps to improve experiences for dually eligible beneficiaries who are enrolled in Dual Eligible Special Needs Plans (D-SNPs). D-SNPs are plans offered by MA organizations that enroll individuals who are eligible for both Medicare and Medicaid. The proposed rule would require that MA organizations with a D-SNP establish, maintain, and consult with one or more enrollee advisory committees to ensure the experiences of people with both Medicare and Medicaid are considered in plan decision making. The proposed rule would also simplify materials that describe how to access Medicare and Medicaid services and streamline the grievance and appeals processes in certain D-SNPs. The rule also proposes a change to MA cost-sharing rules that would result in more equitable payments to providers who serve dually eligible individuals and may improve dually eligible individuals’ access to providers.

In addition, CMS is proposing actions that reduce health disparities by ensuring that all MA special needs plans solicit information about an individual’s barriers to accessing care, through standardized questions in required health risk assessments on housing instability, food insecurity, and transportation. Also, the proposed rule seeks to protect people with Medicare by ensuring they receive accurate and accessible information about Medicare coverage. For example, CMS is proposing to strengthen oversight of third-party marketing organizations that act, directly or indirectly, on behalf of MA organizations and Part D sponsors. These changes include requiring that MA and Part D plans provide information in all required beneficiary communications about the availability of free translation services.

This proposed rule also protects beneficiaries by holding plans to a higher standard when reviewing applications for new or expanded MA plans by requiring that plan applicants demonstrate a sufficient network of contracted providers to care for beneficiaries. CMS also proposes to limit MA plans’ ability to expand or enter into new contracts if their previous performance is poor. This rule further protects beneficiaries by clarifying requirements for plans during disasters and emergencies to ensure that beneficiaries have uninterrupted access to needed services.

CMS is also proposing to hold plans more accountable for how Medicare revenue is spent, including providing greater transparency regarding the amounts used to provide supplemental benefits (e.g., dental, vision, hearing, transportation, meals) by requiring MA and Part D plans to expand reporting of information on the percent of plan revenue spent on patient care and quality improvement activities, known as the medical loss ratio.

In order to increase our understanding of issues related to access to behavioral health care for enrollees in MA plans, the agency also seeks feedback on the challenges with building behavioral health provider networks within MA health plans and the overall impact of potential CMS policy changes on network adequacy and behavioral health access in MA plans.

For a fact sheet detailing the CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P), please visit: https://www.cms.gov/newsroom/fact-sheets/cy-2023-medicare-advantage-and-part-d-proposed-rule-cms-4192-p.

To view the proposed rule, please visit: https://www.federalregister.gov/public-inspection.

New Guidance on Medicaid Payment for Mobile Crisis Services Released

The Centers for Medicare & Medicaid Services (CMS) issued guidance to state Medicaid officials on the scope of and payments for qualifying community-based mobile crisis intervention services authorized by the American Rescue Plan Act of 2021.  The guidance describes the requirements for qualifying services and provider qualifications, options for provider payments, and the requirements for receiving an increased federal share of costs.  States are encouraged to take into account additional travel time when developing services for rural areas.  Research has found higher proportions of rural populations have mental illness and substance use disorder compared to urban as well as challenges accessing care.

Message From HRSA’s New Administrator Carole Johnson

I am Carole Johnson, and this week, I am joining HRSA as the Administrator.  I am especially delighted to join HRSA in this role, having spent time earlier in my career as part of the agency’s health care workforce team.  Returning to HRSA as Administrator is an honor, and I look forward to working each day with the incredibly committed staff, grantees and partners who make up the HRSA community.  I want to share my appreciation for Deputy Administrator Diana Espinosa’s dedication to the communities that HRSA serves and leadership as Acting Administrator over the past year.

Like you, I am deeply committed to HRSA’s mission of improving health outcomes and achieving health equity.  I have seen firsthand HRSA’s tireless efforts to provide equitable access to COVID-19 vaccination and services and to support health care providers struggling with the financial impacts of the pandemic through my work with the White House COVID-19 Response Team.  As Commissioner of the New Jersey Department of Human Services, which provides health care and social services to one-in-five New Jerseyans, I saw the impact of HRSA programs on ensuring access to affordable primary care, supporting health professionals who serve in underserved communities, and reducing disparities in infant and maternal health outcomes and HIV care.  I have also had the opportunity to work closely with HRSA and others inside and outside of government on implementing the Affordable Care Act and combating the opioid epidemic.

It’s an extraordinary list of services and supports that this team delivers in communities across the country, and it only happens with the help and partnership of so many community leaders.  I look forward to hearing your thoughts and feedback on how we can become an even stronger agency as we work to advance health equity and improve access to care and services for those who need it most.

With best wishes for the new year,

Carole Johnson

ARC Welcomes Governor Larry Hogan as 2022 States’ Co-Chair

The Appalachian Regional Commission (ARC) is pleased to announce that Maryland Governor Larry Hogan has been selected to serve as their states’ co-chair for 2022.

Governor Hogan will be working collaboratively with all 13 Appalachian states and the ARC federal office to advance the strategic investment priorities in ARC’s 2022-2026 Strategic Plan.

During FY 2021, ARC invested more than $163 million in the Region, which is projected to leverage an additional $1.04 billion in private investments, create or retain nearly 21,000 jobs, and train over 25,000 students, workers, and leaders in new skills across Appalachia.